CMS Innovation Center Tapped To Consider Models Targeting Prescription Drug Spending

HHS’ drug price control plan calls for CMS demonstrations that target rebates and pharmacy price concessions and that enlist doctors to control total cost of care. CMS’ innovation center could run small-scale mandatory models in Part B that link drug payment to patient outcomes and health disparities. HHS suggests CMS test a policy of rewarding doctors who choose high-value, less-expensive therapies by sharing Part B savings from generics and biosimilars with them. Employer-sponsored plans also could participate. The demo also...